Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1996
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2006 1
2008 1
2009 1
2010 1
2011 1
2013 2
2016 1
2017 2
2022 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Malignant migrating partial seizures in infancy.
Coppola G. Coppola G. Handb Clin Neurol. 2013;111:605-9. doi: 10.1016/B978-0-444-52891-9.00062-2. Handb Clin Neurol. 2013. PMID: 23622207 Review.
The syndrome of malignant migrating partial seizures in infancy (MMPSI) was first reported in 1995, and is now included among the childhood epileptic syndromes in the revision proposal of the ILAE Commission on classification and terminology. Th …
The syndrome of malignant migrating partial seizures in infancy (MMPSI) was first reported in 1995, and i …
Malignant migrating partial seizures in infancy: an epilepsy syndrome of unknown etiology.
Coppola G. Coppola G. Epilepsia. 2009 May;50 Suppl 5:49-51. doi: 10.1111/j.1528-1167.2009.02121.x. Epilepsia. 2009. PMID: 19469847 Free article. Review.
The syndrome of malignant migrating partial seizures in infancy was first reported in 1995, and is now included among the childhood epilepsy syndromes in development in the proposal of the revision of the International League Against Epilepsy (I …
The syndrome of malignant migrating partial seizures in infancy was first reported in 1995, and is now in …
Stiripentol in the Management of Epilepsy.
Nickels KC, Wirrell EC. Nickels KC, et al. CNS Drugs. 2017 May;31(5):405-416. doi: 10.1007/s40263-017-0432-1. CNS Drugs. 2017. PMID: 28434133 Review.
Small case series have also suggested benefit for malignant migrating partial seizures in infancy, super-refractory status epilepticus, and intractable focal epilepsy, although larger prospective studies are needed in these disorders....
Small case series have also suggested benefit for malignant migrating partial seizures in infancy, super- …
Small-molecule inhibitors of Slack potassium channels as potential therapeutics for childhood epilepsies.
M Qunies A, A Emmitte K. M Qunies A, et al. Pharm Pat Anal. 2022 Mar;11(2):45-56. doi: 10.4155/ppa-2022-0002. Epub 2022 Apr 4. Pharm Pat Anal. 2022. PMID: 35369761 Free PMC article. Review.
Several KCNT1 gain of function mutations have been linked to malignant migrating partial seizures of infancy. Quinidine is an anti-arrhythmic drug that functions as a moderately potent inhibitor of Slack channels; however, quinidine use is limit …
Several KCNT1 gain of function mutations have been linked to malignant migrating partial seizures of infancy
Epilepsy syndromes in infancy.
Korff CM, Nordli DR Jr. Korff CM, et al. Pediatr Neurol. 2006 Apr;34(4):253-63. doi: 10.1016/j.pediatrneurol.2005.08.005. Pediatr Neurol. 2006. PMID: 16638498 Review.
This article reviews the clinical presentation, electroencephalographic findings, evolution, and management of the following entities: early infantile epileptic encephalopathy, early myoclonic epilepsy, infantile spasms/West syndrome, severe myoclonic epilepsy of infancy, …
This article reviews the clinical presentation, electroencephalographic findings, evolution, and management of the following entities: early …
Genetics of the epilepsies: where are we and where are we going?
Helbig I, Lowenstein DH. Helbig I, et al. Curr Opin Neurol. 2013 Apr;26(2):179-85. doi: 10.1097/WCO.0b013e32835ee6ff. Curr Opin Neurol. 2013. PMID: 23429546 Free PMC article. Review.
Most importantly, PRRT2 was identified as the long-sought gene for benign familial infantile seizures. Mutations in KCNT1 were found in two seemingly unrelated monogenic epilepsies including malignant migrating partial seizures of infancy
Most importantly, PRRT2 was identified as the long-sought gene for benign familial infantile seizures. Mutations in KCNT1 were found …
KCNT1 mutations in seizure disorders: the phenotypic spectrum and functional effects.
Lim CX, Ricos MG, Dibbens LM, Heron SE. Lim CX, et al. J Med Genet. 2016 Apr;53(4):217-25. doi: 10.1136/jmedgenet-2015-103508. Epub 2016 Jan 6. J Med Genet. 2016. PMID: 26740507 Review.
KCNT1 missense mutations have been found in 39% of patients with the epileptic encephalopathy malignant migrating focal seizures of infancy (MMFSI), making it the most significant MMFSI disease-causing gene identified to date. ...
KCNT1 missense mutations have been found in 39% of patients with the epileptic encephalopathy malignant migrating focal sei
Malignant epileptic encephalopathies in children.
Dulac OJ, Chiron C. Dulac OJ, et al. Baillieres Clin Neurol. 1996 Dec;5(4):765-81. Baillieres Clin Neurol. 1996. PMID: 9068880 Review.
Malignant epileptic encephalopathies in children comprise a series of age-related generalized epilepsy syndromes: neonatal myoclonic encephalopathy and early epileptic encephalopathy in the neonatal period, migrating focal seizures in early infancy, in
Malignant epileptic encephalopathies in children comprise a series of age-related generalized epilepsy syndromes: neonatal myoclonic
Epileptic syndromes in infancy and childhood.
Nabbout R, Dulac O. Nabbout R, et al. Curr Opin Neurol. 2008 Apr;21(2):161-6. doi: 10.1097/WCO.0b013e3282f7007e. Curr Opin Neurol. 2008. PMID: 18317274 Review.
RECENT FINDINGS: In addition to those included in the classification of the International League Against Epilepsy, new epilepsy syndromes comprise febrile seizures plus, benign familial neonatal-infantile seizures (BFNIS), benign infantile focal epilepsy with midlin …
RECENT FINDINGS: In addition to those included in the classification of the International League Against Epilepsy, new epilepsy syndromes co …
[Epileptic encephalopathies in infancy. How do we treat them? Does the aetiology influence the response to treatment?].
Roldan S. Roldan S. Rev Neurol. 2017 May 17;64(s03):S71-S75. Rev Neurol. 2017. PMID: 28524224 Free article. Review. Spanish.
INTRODUCTION: Resistance to treatments is a common feature of Ohtahara, Aicardi, West and Dravet syndromes, as well as malignant migrating epilepsy in infancy. AIMS: To update the therapeutic management and to analyse whether the aetiology somehow determines …
INTRODUCTION: Resistance to treatments is a common feature of Ohtahara, Aicardi, West and Dravet syndromes, as well as malignant m
11 results